Loading...
Perspectives for repurposing drugs for the coronavirus disease 2019
The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East respiratory syndrome CoV (MERS-CoV), has been associated with high infection rates with over 36,405 deaths. In the absence of approved market...
Saved in:
| Published in: | Indian J Med Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer - Medknow
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357399/ https://ncbi.nlm.nih.gov/pubmed/32317408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_585_20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|